Yozgat, A. Et Al. 2021. Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4 , 1675-1681.

Yozgat, A., Kasapoglu, B., CAN, G., Tanoglu, A., Sakin, Y. S., Yalcin, K. S., ... Gurler, M.(2021). Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, 1675-1681.

Yozgat, Ahmet Et Al. "Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, 1675-1681, 2021

Yozgat, Ahmet Et Al. "Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, pp.1675-1681, 2021

Yozgat, A. Et Al. (2021) . "Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, pp.1675-1681.

@article{article, author={Ahmet Yozgat Et Al. }, title={Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2021, pages={1675-1681} }